PMID- 26867395 OWN - NLM STAT- MEDLINE DCOM- 20160421 LR - 20181202 IS - 0125-1562 (Print) IS - 0125-1562 (Linking) VI - 46 IP - 4 DP - 2015 Jul TI - SAFETY OF A CRM197-CONJUGATED HAEMOPHILUS INFLUENZAE TYPE B VACCINE IN KOREAN CHILDREN. PG - 743-52 AB - Haemophilus influenzae type b (Hib) is a major cause of meningitis and pneumonia with high morbidity and mortality rates in young children. The introduction of effective and well-tolerated conjugate Hib vaccines, has nearly eradicated this disease in many countries. We investigated the safety of the Hib PRP-CRM197 vaccine in a multi-center post-marketing surveillance (PMS) study. Korean children (N = 764) aged 1-33 months were enrolled when receiving a routine primary immunization or a booster vaccine with Hib PRP-CRM197 and solicited and unsolicited adverse events (AEs) were recorded using a diary card for 7 and 28 days after each vaccination, respectively. In this study, AEs were reported by 66% of subjects but were generally mild, with 42% of subjects reporting solicited AEs and 46% reporting unsolicited AEs. Among the unsolicited AEs, 98% were determined to be unrelated to the study vaccine. The studied Hib PRP-CRM197 vaccine was well tolerated by the study group and found to have a similar safety profile to that reported in other clinical studies. This vaccine is suitable for routine immunization against Hib disease among Korean children. AEs due to this vaccine will continue to be monitored. FAU - Song, Hyoyoung AU - Song H FAU - Bock, Hans AU - Bock H FAU - Guadagno, Alana AU - Guadagno A FAU - Costantini, Marco AU - Costantini M FAU - Baehner, Frank AU - Baehner F FAU - Kim, Yeon Ho AU - Kim YH FAU - Ahn, Seung In AU - Ahn SI FAU - Son, Ki Hyuk AU - Son KH FAU - Yim, Dong-Seok AU - Yim DS LA - eng PT - Clinical Study PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - Thailand TA - Southeast Asian J Trop Med Public Health JT - The Southeast Asian journal of tropical medicine and public health JID - 0266303 RN - 0 (Antigens, Bacterial) RN - 0 (Bacterial Proteins) RN - 0 (Diphtheria Toxoid) RN - 0 (Haemophilus Vaccines) RN - 0 (Haemophilus influenzae type b polysaccharide vaccine) RN - 0 (Haemophilus influenzae type b-polysaccharide vaccine-diphtheria toxoid conjugate) RN - 08VC9WC084 (CRM197 (non-toxic variant of diphtheria toxin)) SB - IM MH - Antigens, Bacterial/immunology MH - Bacterial Capsules MH - Bacterial Proteins/adverse effects MH - Child, Preschool MH - Diphtheria/*prevention & control MH - Diphtheria Toxoid/*adverse effects MH - Erythema/*chemically induced MH - Female MH - Haemophilus Infections/*prevention & control MH - Haemophilus Vaccines/*adverse effects MH - Haemophilus influenzae type b/immunology MH - Humans MH - Immunization, Secondary MH - Infant MH - Infant, Newborn MH - Irritable Mood MH - Male MH - Pain/*chemically induced MH - Product Surveillance, Postmarketing MH - Republic of Korea EDAT- 2016/02/13 06:00 MHDA- 2016/04/22 06:00 CRDT- 2016/02/13 06:00 PHST- 2016/02/13 06:00 [entrez] PHST- 2016/02/13 06:00 [pubmed] PHST- 2016/04/22 06:00 [medline] PST - ppublish SO - Southeast Asian J Trop Med Public Health. 2015 Jul;46(4):743-52.